These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34488117)

  • 21. Brain Drug Delivery Systems for the Stroke Intervention and Recovery.
    Luo T; Wang J; Hao S; Guo T; Ren P; Cheng Z; Gao F; Gong Y; Wang B
    Curr Pharm Des; 2017; 23(15):2258-2267. PubMed ID: 27784243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
    Ma H; Jiang Z; Xu J; Liu J; Guo ZN
    Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances of nano drug delivery system for the theranostics of ischemic stroke.
    Lv W; Liu Y; Li S; Lv L; Lu H; Xin H
    J Nanobiotechnology; 2022 May; 20(1):248. PubMed ID: 35641956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dodging blood brain barrier with "nano" warriors: Novel strategy against ischemic stroke.
    Parvez S; Kaushik M; Ali M; Alam MM; Ali J; Tabassum H; Kaushik P
    Theranostics; 2022; 12(2):689-719. PubMed ID: 34976208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferential Targeting Cerebral Ischemic Lesions with Cancer Cell-Inspired Nanovehicle for Ischemic Stroke Treatment.
    He W; Mei Q; Li J; Zhai Y; Chen Y; Wang R; Lu E; Zhang XY; Zhang Z; Sha X
    Nano Lett; 2021 Apr; 21(7):3033-3043. PubMed ID: 33755480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective Peptides and New Strategies for Ischemic Stroke Drug Discoveries.
    Dergunova LV; Filippenkov IB; Limborska SA; Myasoedov NF
    Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug delivery to the ischemic brain.
    Thompson BJ; Ronaldson PT
    Adv Pharmacol; 2014; 71():165-202. PubMed ID: 25307217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain Targeting, Antioxidant Polymeric Nanoparticles for Stroke Drug Delivery and Therapy.
    Wu H; Peng B; Mohammed FS; Gao X; Qin Z; Sheth KN; Zhou J; Jiang Z
    Small; 2022 Jun; 18(22):e2107126. PubMed ID: 35306743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment.
    Xiang H; Zhang Q; Han Y; Yang L; Zhang Y; Liu Q; Zhang Z; Zhang L
    J Control Release; 2021 Jul; 335():498-514. PubMed ID: 34087248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?
    Bu ZQ; Yu HY; Wang J; He X; Cui YR; Feng JC; Feng J
    ASN Neuro; 2021; 13():17590914211037505. PubMed ID: 34463559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing the drug delivery strategies in ischemic stroke therapy.
    Wu Q; Yan R; Sun J
    Drug Deliv; 2020 Nov; 27(1):1644-1655. PubMed ID: 33241704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic stroke.
    Spitzer D; Guérit S; Puetz T; Khel MI; Armbrust M; Dunst M; Macas J; Zinke J; Devraj G; Jia X; Croll F; Sommer K; Filipski K; Freiman TM; Looso M; Günther S; Di Tacchio M; Plate KH; Reiss Y; Liebner S; Harter PN; Devraj K
    Acta Neuropathol; 2022 Aug; 144(2):305-337. PubMed ID: 35752654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in Engineered Nanoparticles for the Treatment of Ischemic Stroke by Enhancing Angiogenesis.
    Wang G; Li Z; Wang G; Sun Q; Lin P; Wang Q; Zhang H; Wang Y; Zhang T; Cui F; Zhong Z
    Int J Nanomedicine; 2024; 19():4377-4409. PubMed ID: 38774029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances in Targeted Nanotherapies for Ischemic Stroke.
    Liao J; Li Y; Luo Y; Meng S; Zhang C; Xiong L; Wang T; Lu Y
    Mol Pharm; 2022 Sep; 19(9):3026-3041. PubMed ID: 35905397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke.
    Fukuta T; Oku N; Kogure K
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity After Ischemic Stroke.
    Gao L; Song Z; Mi J; Hou P; Xie C; Shi J; Li Y; Manaenko A
    Curr Neuropharmacol; 2020; 18(12):1213-1226. PubMed ID: 32928089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanotechnology based diagnostic and therapeutic strategies for neuroscience with special emphasis on ischemic stroke.
    Nair SB; Dileep A; Rajanikant GK
    Curr Med Chem; 2012; 19(5):744-56. PubMed ID: 22204347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequentially Site-Specific Delivery of Thrombolytics and Neuroprotectant for Enhanced Treatment of Ischemic Stroke.
    Xu J; Wang X; Yin H; Cao X; Hu Q; Lv W; Xu Q; Gu Z; Xin H
    ACS Nano; 2019 Aug; 13(8):8577-8588. PubMed ID: 31339295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The criteria for effectiveness of reperfusion therapy and neuroprotective therapy in ischemic stroke].
    Zakharov VV; Vakhnina NV; Gogoleva AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(4):86-92. PubMed ID: 34037360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of bionanoparticles based on Angelica polysaccharides for the treatment of stroke.
    Su Y; Guo C; Chen Q; Guo H; Wang J; Mu K; Chen D
    Nanomedicine; 2022 Aug; 44():102570. PubMed ID: 35623564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.